NEW YORK - Pharmaceutical company Perrigo Co. said it will expand its facilities in Allegan, Mich., adding 400 jobs and investing $10.5 million as it steps up development of generic drugs.
| PRGO | 34.7 |
The company said it will provide operations and training space at its headquarters and plans to add the jobs over the next five years.
"Many brand products' exclusivity rights will expire soon, and this will allow us to develop additional high-quality, store-brand versions at an affordable price," said Joseph Papa, president, chairman and chief executive of Perrigo.
The moves will be aided by tax credits from the state of Michigan, which the company valued at $8.4 million over the next 12 years. It also expects the city of Allegan to approve tax abatements worth an estimated $1.4 million.
According to data from IMS Health, drugs worth $66.4 billion in annual sales will lose patent protection between 2008 and 2012, including products worth more than $40 billion in 2011 and 2012.
Perrigo shares gained $1.13, or 3.2 percent, to $36.18 in afternoon trading.

The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
India pledged Friday not to engage in a new arms race as talks continued in Vienna over whether to let the U.S. sell India nuclear material and t...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...


Professional Website Design For Corporate - Get a Free Quote Today